Provided by Tiger Trade Technology Pte. Ltd.

Tonix Pharmaceuticals

13.66
+1.219.72%
Post-market: 13.52-0.1400-1.02%19:54 EDT
Volume:1.14M
Turnover:15.44M
Market Cap:234.28M
PE:-1.09
High:13.95
Open:12.56
Low:12.50
Close:12.45
52wk High:34.89
52wk Low:9.40
Shares:17.15M
Float Shares:14.99M
Volume Ratio:3.23
T/O Rate:7.62%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-12.4882
EPS(LYR):-14.5713
ROE:-81.82%
ROA:-46.84%
PB:1.05
PE(LYR):-0.94

Loading ...

Aug 19, 2026

Major Issues Report

Form 8-K - Current report
Aug 14, 2026

Beneficial Ownership Change

Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
Aug 13, 2026

Beneficial Ownership Change

Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors
Aug 10, 2026

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Aug 10, 2026

Major Issues Report

Form 8-K - Current report
Aug 03, 2026

Major Issues Report

Form 8-K - Current report
Jul 21, 2026

Major Issues Report

Form 8-K - Current report
Jul 13, 2026

Major Issues Report

Form 8-K - Current report
Jul 02, 2026

Employee Stock Ownership

Form S-8 - Securities to be offered to employees in employee benefit plans
Jun 29, 2026

Major Issues Report

Form 8-K - Current report
Jun 15, 2026

Beneficial Ownership Change

Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors
Jun 08, 2026

Major Issues Report

Form 8-K - Current report
May 27, 2026

Major Issues Report

Form 8-K - Current report
May 15, 2026

Beneficial Ownership Change

Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
May 15, 2026

Major Issues Report

Form 8-K - Current report
May 15, 2026

Beneficial Ownership Change

Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors
May 11, 2026

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
May 11, 2026

Major Issues Report

Form 8-K - Current report
May 07, 2026

Major Issues Report

Form 8-K - Current report
May 06, 2026

Major Issues Report

Form 8-K - Current report